Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today shared updates from its clinical programs focused on limb-girdle muscular dystrophy (LGMD) subtypes 2C/R5 ...

Despite the PNG award termination, GeoVax anticipates a milestone-rich 2025 across its portfolio. The Company will continue to engage with government and industry partners, pursue clinical trial ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD's Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has received Investigational New Drug (IND) ...

Recently, the first-ever OpenHarmony Technical Forum in Europe successfully concluded in Rotterdam, the Netherlands. Centered on the theme of “OpenHarmony Technology Innovation and Ecosystem Practice, ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, today announced the publication of a peer ...

I first became interested in laser engraving because it transforms simple materials into personalized pieces of art. I was ...

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a market size of USD 24.6 Billion by 2032 growing at a CAGR of 18.5% from ...

ML is one of the cornerstones of AI in manufacturing. It has been used for over a decade and is often applied to individual ...

The main problem is that most vector production technologies were developed for the lab, rather than to support industrial ...

Most CPGs' digital transformation began on the business side, with supply chain optimization, demand planning, and ...

Request To Download Free Sample of This Strategic Report @ https://reportocean.com/industry-verticals/sample-request?report_id=VIT677 This country research report on ...